Trademark Overview
On Wednesday, July 8, 2026, a trademark application was filed for QYN with the United States Patent and Trademark Office. The USPTO has given the QYN trademark a serial number of 99929330. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 8, 2026. This trademark is owned by Qyn Labs, Inc. The QYN trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Hormone testing kits comprised of medical diagnostic reagents and assay components for measuring hormone levels for medical purposes; medical diagnostic testing kits comprised of reagents and assay components for detecting and measuring biomarkers for medical purposes
Health and wellness services, namely, providing information and consulting in the field of hormonal health and balance; providing medical and health information based on analysis of biomarkers; providing clinical decision support services, namely, providing medical information and treatment recommendations based on biomarker data
Downloadable mobile application software for tracking, analyzing, and managing hormone-related health data; downloadable software for collecting, processing, and analyzing biomarker data, including patient health data; downloadable software featuring clinical decision support tools for use by clinicians, physicians, and healthcare providers in analyzing biomarker data and generating diagnostic and treatment recommendations; downloadable software for use by pharmaceutical companies in analyzing biomarker data for drug development and clinical research
Providing temporary use of non-downloadable software for analyzing hormone test data and generating reports; providing temporary use of non-downloadable software for analyzing biomarker data and generating reports; software as a service (SaaS) services featuring software for processing, aggregating, and interpreting patient biomarker data; providing temporary use of non-downloadable clinical decision support software for use by clinicians, physicians, and healthcare providers to analyze biomarker data and generate diagnostic and treatment recommendations; providing temporary use of non-downloadable software for use by pharmaceutical companies in biomarker analysis, drug development, and clinical trial optimization